Hilde Berner Hammer

5.7k total citations
138 papers, 3.2k citations indexed

About

Hilde Berner Hammer is a scholar working on Rheumatology, Surgery and Hematology. According to data from OpenAlex, Hilde Berner Hammer has authored 138 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Rheumatology, 27 papers in Surgery and 26 papers in Hematology. Recurrent topics in Hilde Berner Hammer's work include Rheumatoid Arthritis Research and Therapies (78 papers), Musculoskeletal synovial abnormalities and treatments (28 papers) and Autoimmune and Inflammatory Disorders Research (26 papers). Hilde Berner Hammer is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (78 papers), Musculoskeletal synovial abnormalities and treatments (28 papers) and Autoimmune and Inflammatory Disorders Research (26 papers). Hilde Berner Hammer collaborates with scholars based in Norway, Denmark and United States. Hilde Berner Hammer's co-authors include Tore K Kvien, Espen A. Haavardsholm, Till Uhlig, Lene Terslev, Annamaria Iagnocco, Maria Antonietta D’Agostino, Esperanza Naredo, Désirée van der Heijde, Brigitte Michelsen and I.K. Haugen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Nutrition.

In The Last Decade

Hilde Berner Hammer

128 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hilde Berner Hammer Norway	33	2.4k	731	619	587	368	138	3.2k
Carlo Alberto Scirè Italy	32	2.1k 0.9×	670 0.9×	431 0.7×	477 0.8×	296 0.8×	137	3.1k
Sedat Kiraz Türkiye	32	1.2k 0.5×	586 0.8×	645 1.0×	719 1.2×	798 2.2×	195	3.9k
Е. Л. Насонов Russia	25	2.1k 0.9×	782 1.1×	267 0.4×	847 1.4×	464 1.3×	399	3.2k
Ömer Karadağ Türkiye	26	940 0.4×	406 0.6×	517 0.8×	544 0.9×	580 1.6×	215	2.6k
Umut Kalyoncu Türkiye	26	993 0.4×	513 0.7×	332 0.5×	606 1.0×	553 1.5×	206	2.4k
İhsan Ertenli Türkiye	28	997 0.4×	513 0.7×	331 0.5×	525 0.9×	677 1.8×	155	2.7k
Meral Çalgünerı Türkiye	31	1.1k 0.4×	458 0.6×	505 0.8×	558 1.0×	821 2.2×	98	3.2k
Irene E. van der Horst‐Bruinsma Netherlands	33	3.0k 1.3×	615 0.8×	290 0.5×	1.2k 2.1×	395 1.1×	85	3.7k
Helena Forsblad‐d’Elia Sweden	37	2.3k 1.0×	587 0.8×	274 0.4×	1.0k 1.7×	652 1.8×	121	3.5k
Frédérique Gandjbakhch France	30	2.2k 0.9×	785 1.1×	454 0.7×	606 1.0×	105 0.3×	70	2.8k

Countries citing papers authored by Hilde Berner Hammer

Since Specialization

Citations

This map shows the geographic impact of Hilde Berner Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Berner Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Berner Hammer more than expected).

Fields of papers citing papers by Hilde Berner Hammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Berner Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Berner Hammer. The network helps show where Hilde Berner Hammer may publish in the future.

Co-authorship network of co-authors of Hilde Berner Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Berner Hammer. A scholar is included among the top collaborators of Hilde Berner Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Berner Hammer. Hilde Berner Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uhlig, Till, et al.. (2025). Remission in gout is possible: 5-year follow-up in the NOR-Gout study. Seminars in Arthritis and Rheumatism. 72. 152698–152698. 1 indexed citations

Halse, Anne‐Kristine, et al.. (2025). Calprotectin (S100A8/A9) is not associated with ultrasound-detected synovitis in a longitudinal study of patients with psoriatic arthritis treated with biological disease-modifying anti-rheumatic drugs. Scandinavian Journal of Rheumatology. 55(1). 51–58.

Uhlig, Till, Joe Sexton, Sella Aarrestad Provan, et al.. (2024). Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. Lara D. Veeken. 64(4). 1799–1806. 3 indexed citations

Hammer, Hilde Berner, et al.. (2023). Associations Between Pain Sensitization And Measures Of Physical Function In People With Hand Osteoarthritis: Results From The Nor-Hand Study. Osteoarthritis and Cartilage. 31. S364–S366. 1 indexed citations

Uhlig, Till, et al.. (2023). Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study. Lara D. Veeken. 62(12). 3886–3892.

Neogi, Tuhina, et al.. (2023). Associations between pain sensitization and measures of physical function in people with hand osteoarthritis: Results from the Nor-Hand study. Osteoarthritis and Cartilage. 31(10). 1388–1395. 3 indexed citations

Möller, Ingrid, Juan Blasi, Hilde Berner Hammer, et al.. (2023). Ultrasound assessment of degenerative muscle sarcopenia: the University of Barcelona ultrasound scoring system for sarcopenia. RMD Open. 9(1). e002779–e002779. 4 indexed citations

Westerlind, Helga, Bente Glintborg, Hilde Berner Hammer, et al.. (2023). Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts. RMD Open. 9(3). e003027–e003027. 11 indexed citations

Delcoigne, Bénédicte, Sella Aarrestad Provan, Hilde Berner Hammer, et al.. (2022). Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration. Lara D. Veeken. 61(11). 4286–4296. 4 indexed citations

10.

Sundin, Ulf, Anna‐Birgitte Aga, Joseph Sexton, et al.. (2021). Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy. RMD Open. 7(1). e001525–e001525. 17 indexed citations

11.

Provan, Sella Aarrestad, et al.. (2020). Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy. RMD Open. 6(3). e001372–e001372. 5 indexed citations

12.

Hammer, Hilde Berner, Brigitte Michelsen, Joseph Sexton, et al.. (2019). Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis. Annals of the Rheumatic Diseases. 78(9). 1179–1185. 35 indexed citations

13.

Provan, Sella Aarrestad, Silvia Rollefstad, Eirik Ikdahl, et al.. (2019). Biomarkers of cardiovascular risk across phenotypes of osteoarthritis. BMC Rheumatology. 3(1). 33–33. 5 indexed citations

14.

Aga, Anna‐Birgitte, Inge Christoffer Olsen, Hilde Berner Hammer, et al.. (2018). Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Annals of the Rheumatic Diseases. 77(10). 1421–1425. 28 indexed citations

15.

Michelsen, Brigitte, Till Uhlig, Joseph Sexton, et al.. (2018). Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Annals of the Rheumatic Diseases. 77(9). 1290–1294. 22 indexed citations

16.

Nordberg, Lena Bugge, Siri Lillegraven, Anna‐Birgitte Aga, et al.. (2018). Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. RMD Open. 4(2). e000752–e000752. 41 indexed citations

17.

Nordberg, Lena Bugge, Siri Lillegraven, Elisabeth Lie, et al.. (2016). Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria. Annals of the Rheumatic Diseases. 76(2). 341–345. 87 indexed citations

18.

Aga, Anna‐Birgitte, Hilde Berner Hammer, Inge Christoffer Olsen, et al.. (2015). First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach. Annals of the Rheumatic Diseases. 75(8). 1444–1451. 13 indexed citations

19.

Hammer, Hilde Berner, Annamaria Iagnocco, Alexander Mathiessen, et al.. (2014). Global ultrasound assessment of structural lesions in osteoarthritis: a reliability study by the OMERACT ultrasonography group on scoring cartilage and osteophytes in finger joints. Annals of the Rheumatic Diseases. 75(2). 402–407. 48 indexed citations

20.

Maksymowych, Walter P., Robert Landewé, Joan M. Bathon, et al.. (2012). Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria. Data Archiving and Networked Services (DANS). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact